FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

H Lehmann

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Wolfgang Löscher; H Lehmann; Hans-Jürgen Teschendorf; M Traut; G Gross
Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
Ulrich Ebert; Chris Rundfeldt; H Lehmann; Wolfgang Löscher
Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: influence of experimental and environmental factors.
Wolfgang Löscher; H Lehmann; B Behl; D Seemann; Hans-Jürgen Teschendorf; Hans-Peter Hofmann; Wilfried Lubisch; T Höger; H G Lemaire; G Gross
A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of H Lehmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1999: Wolfgang Löscher; H Lehmann; Hans-Jürgen Teschendorf; M Traut; G Gross
Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
The Journal of pharmacology and experimental therapeutics 1999;288(3):984-92.
1999: Ulrich Ebert; Chris Rundfeldt; H Lehmann; Wolfgang Löscher
Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: influence of experimental and environmental factors.
Epilepsy research 1999;33(2-3):199-215.
1999: Wolfgang Löscher; H Lehmann; B Behl; D Seemann; Hans-Jürgen Teschendorf; Hans-Peter Hofmann; Wilfried Lubisch; T Höger; H G Lemaire; G Gross
A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
The European journal of neuroscience 1999;11(1):250-62.
1998: Wolfgang Löscher; H Lehmann
Anticonvulsant efficacy of L-deprenyl (selegiline) during chronic treatment in mice: continuous versus discontinuous administration.
Neuropharmacology 1998;37(12):1587-93.
1998: H Lehmann; Ulrich Ebert; Wolfgang Löscher
Amygdala-kindling induces a lasting reduction of GABA-immunoreactive neurons in a discrete area of the ipsilateral piriform cortex.
Synapse (New York, N.Y.) 1998;29(4):299-309.
1998: Wolfgang Löscher; Ulrich Ebert; H Lehmann; C Rosenthal; G Nikkhah
Seizure suppression in kindling epilepsy by grafts of fetal GABAergic neurons in rat substantia nigra.
Journal of neuroscience research 1998;51(2):196-209.
1996: H Lehmann; Ulrich Ebert; Wolfgang Löscher
Immunocytochemical localization of GABA immunoreactivity in dentate granule cells of normal and kindled rats.
Neuroscience letters 1996;212(1):41-4.
1996: Wolfgang Löscher; Ulrich Ebert; H Lehmann
Kindling induces a lasting, regionally selective increase of kynurenic acid in the nucleus accumbens.
Brain research 1996;725(2):252-6.